Asian Stocks to Waver as US Shrugs Off Tariffs: Markets Wrap
Stocks in Asia are set for a mixed open after investors looked past Donald Trump’s tariff plan to lift the US benchmark to ...
Experts: How Trump's healthcare picks could impact global health
President-elect Donald Trump's nominees for the country's top health agencies and his previous track record in office have ...
South Korea to roll out $10 billion in loans next year to support chip industry
South Korea plans to roll out 14 trillion won ($10 billion) of low-interest loans next year to support its chip industry, the ...
MARPAI ANNOUNCES GENERAL UPDATES FOR Q4
Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, operates as a national Third-Party ...
Ransomware attack on software supplier disrupts operations for Starbucks and other retailers
A ransomware attack that hit a major software provider last week caused disruptions for a handful of companies over recent days, from Starbucks to U.K. grocery giant Morrisons. Blue Yonder, which ...
Is Coca-Cola (KO) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Coca-Cola (KO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...
Goldman strategists outline five reflation, tariff hedges for 2025
As the 'Goldilocks' market backdrop over the past year moves into the rearview mirror, the prospect of a reflationary environment following a Republican sweep threatens risky assets, Goldman Sachs ...
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug ...